Press Release: Halo Pharmaceutical : The Noramco Group Invests $25 Million in Halo Pharma's Whippany Facility to Offer Sterile Injectable Manufacturing

New High-Speed Filling Line to Support Growing Demand for Sterile Injectables and Strengthen Domestic Supply Chain Learn More About Halo Pharmas New Sterile Manufacturing Capabilities at DCAT Week...